Regulating stress response to promote postnatal beta-cell function and survival

调节应激反应以促进产后 β 细胞功能和存活

基本信息

  • 批准号:
    10199281
  • 负责人:
  • 金额:
    $ 48.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Workload-induced pancreatic islet β-cell dysfunction, loss-of identity, and cell death, commonly known as β-cell failure, is the hallmark of type 2 diabetes (T2D). This disease usually starts with obesity-induced insulin resistance, when peripheral tissues need higher levels of circulating insulin for glucose storage and usage. Islet β-cells compensate by expanding β-cell mass and increasing insulin output per cell, which requires upregulated insulin biosynthesis and oxidative glucose metabolism. These produce unfolded proinsulin in the ER and reactive oxygen species (ROS) in mitochondria, which at high levels can decimate β cells. Thus, β cells constantly activate stress response by stimulating the activity of several early-stage SRGs, including Atf6, IRE1, PERK, Hsf1, and Nurf2, to lead to: 1) attenuated overall protein translation; 2) enhanced translation of some SRG mRNAs that have special features such as upstream open reading frame (uORF) 5’ to the main ORF; 3) upregulated expression of some late-stage SRGs. The overall effect of these responses is to remove unfolded proteins/ROS for proteomic homeostasis and sustainable β-cell function. However, over-activating some late-stage SRGs such as Atf4 and Hsps induces β-cell failure by turning on some proapoptotic genes or by exceedingly lowering overall protein translation. Thus, it is imperative for β-cells to limit the levels of failure- causing SRGs for sustainable high-level of insulin output. An emerging model from our recent published findings is that a transcriptional complex containing Myt TFs and Sin3 can selectively repressing these failure- causing SRGs. Myt TFs are a family of three myelin transcription factors (Myt1, 2, and 3) highly expressed in islet cells. Sin3, including Sin3a and Sin3b, is a coregulator that represses transcription by recruiting histone deacetylases (HDACs) to modify histones. We showed that Myt TFs and Sin3 can form a transcription complex in β cells. Inactivating these genes in mouse and human β cells causes cell dysfunction and/or death while overactivating late-stage β-cell-failure-causing SRGs but not early stage SRGs. Intriguingly, Myt TFs, particularly Myt3, is induced by obesity-related stressors in mouse and human β cells, likely mediated by an uORF in 5’ flanking region of Myt3 mRNA. Importantly, MYT3 down-regulation accompanies human β-cell failure in T2D development. Our overarching hypothesis is that the stress-responsive Myt TFs, particularly Myt3, promote -cell function/survival by repressing late-stage SRGs via Sin3-mediated histone de-acetylation under both normal physiology and metabolic stress. Aim 1 will establish how MYT TFs repress SRG expression in a human β cell line and how manipulating MYT-TF levels will affect primary human β-cell function and survival. Aim 2 will define how metabolic stressors up-regulate Myt3 production and how this upregulation enable β-cell compensation under metabolic stress. We expect to uncover a tunable mechanism that can be explored for preventing/delaying β-cell failure and T2D.
工作负荷诱导的胰岛β细胞功能障碍,身份丧失和细胞死亡,通常被称为

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guoqiang Gu其他文献

Guoqiang Gu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guoqiang Gu', 18)}}的其他基金

Regulating stress response to promote postnatal beta-cell function and survival
调节应激反应以促进产后 β 细胞功能和存活
  • 批准号:
    10580784
  • 财政年份:
    2021
  • 资助金额:
    $ 48.67万
  • 项目类别:
Regulating stress response to promote postnatal beta-cell function and survival
调节应激反应以促进产后 β 细胞功能和存活
  • 批准号:
    10366079
  • 财政年份:
    2021
  • 资助金额:
    $ 48.67万
  • 项目类别:
The DNA methylome-based regulation of functional beta-cell mass
基于 DNA 甲基化组的功能性 β 细胞群调节
  • 批准号:
    10415123
  • 财政年份:
    2020
  • 资助金额:
    $ 48.67万
  • 项目类别:
The DNA methylome-based regulation of functional beta-cell mass
基于 DNA 甲基化组的功能性 β 细胞群调节
  • 批准号:
    10205058
  • 财政年份:
    2020
  • 资助金额:
    $ 48.67万
  • 项目类别:
The DNA methylome-based regulation of functional beta-cell mass
基于 DNA 甲基化组的功能性 β 细胞群调节
  • 批准号:
    10033594
  • 财政年份:
    2020
  • 资助金额:
    $ 48.67万
  • 项目类别:
The DNA methylome-based regulation of functional beta-cell mass
基于 DNA 甲基化组的功能性 β 细胞群调节
  • 批准号:
    10647908
  • 财政年份:
    2020
  • 资助金额:
    $ 48.67万
  • 项目类别:
The DNA methylome-based regulation of functional beta-cell mass
基于 DNA 甲基化组的功能性 β 细胞群调节
  • 批准号:
    10287569
  • 财政年份:
    2020
  • 资助金额:
    $ 48.67万
  • 项目类别:
Microtubule Regulation of Pancreatic Beta Cell Function and Diabetes
胰腺β细胞功能和糖尿病的微管调节
  • 批准号:
    10366019
  • 财政年份:
    2016
  • 资助金额:
    $ 48.67万
  • 项目类别:
Microtubule Regulation of Pancreatic Beta Cell Function and Diabetes
胰腺β细胞功能和糖尿病的微管调节
  • 批准号:
    9229554
  • 财政年份:
    2016
  • 资助金额:
    $ 48.67万
  • 项目类别:
Microtubule Regulation of Pancreatic Beta Cell Function and Diabetes
胰腺β细胞功能和糖尿病的微管调节
  • 批准号:
    10597141
  • 财政年份:
    2016
  • 资助金额:
    $ 48.67万
  • 项目类别:

相似海外基金

Influence of the polymorphism of 5'-flanking region of SAA1 gene on SAA1 transcriptional activity
SAA1基因5侧翼区多态性对SAA1转录活性的影响
  • 批准号:
    13670479
  • 财政年份:
    2001
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of The 5'-Flanking Region of the Stress Response Gene, Osp94
应激反应基因 Osp94 5-侧翼区域的表征
  • 批准号:
    12672132
  • 财政年份:
    2000
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mdecular cloning and analysis of S' -flanking region of human MYPT1 gene
人MYPT1基因S侧翼区的分子克隆与分析
  • 批准号:
    10670645
  • 财政年份:
    1998
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANALYSIS OF CYCLIN D1 GENE EXPRESSION BY METHYLATION OF CpG ISLAND LOCATED 5'-FLANKING REGION
5-侧翼区 CpG 岛甲基化分析细胞周期蛋白 D1 基因表达
  • 批准号:
    09670226
  • 财政年份:
    1997
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANALYSIS OF TWO PROMOTERS AND 5'FLANKING REGION OF RAT SERINE : PYRUVATE AMINOTRANSFERASE GENE
大鼠丝氨酸丙酮酸转氨酶基因的两个启动子和5侧翼区的分析
  • 批准号:
    05680546
  • 财政年份:
    1993
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Characterization of 5 prime flanking region of 230 kDa bullous pemphigoid antigen gene
230 kDa 大疱性类天疱疮抗原基因 5 主要侧翼区域的表征
  • 批准号:
    05670718
  • 财政年份:
    1993
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Syndrome of extreme insulin resistance due to decreased promoter activity of 5'-flanking region of insulin receptor gene.
由于胰岛素受体基因 5-侧翼区域启动子活性降低而导致的极端胰岛素抵抗综合征。
  • 批准号:
    03454513
  • 财政年份:
    1991
  • 资助金额:
    $ 48.67万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了